Private Capital Management, LLC Harrow Health, Inc. Transaction History
Private Capital Management, LLC
- $770 Million
- Q1 2025
A detailed history of Private Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Private Capital Management, LLC holds 1,890,627 shares of HROW stock, worth $68.3 Million. This represents 6.53% of its overall portfolio holdings.
Number of Shares
1,890,627
Previous 1,694,983
11.54%
Holding current value
$68.3 Million
Previous $56.9 Million
11.56%
% of portfolio
6.53%
Previous 6.85%
Shares
12 transactions
Others Institutions Holding HROW
# of Institutions
178Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$143 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$77.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$67.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$34.6 Million1.56% of portfolio
-
State Street Corp Boston, MA786KShares$28.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $977M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...